Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Imodium A-D Chewable Tablets

This article was originally published in The Tan Sheet

Executive Summary

Imodium A-D Chewable Tablets: To be introduced later this year, new dosage form of McNeil Consumer Products' loperamide anti-diarrheal (NDA 20-448) is approved by FDA July 24. Liquid, caplet and capsule forms of the product are marketed. The dosage form was designated "approvable" by the agency in May 1996 ("The Tan Sheet" Aug. 5, 1996, In Brief). McNeil is planning to launch another new Imodium product, Imodium Advanced, with loperamide and simethicone, later this year after receiving FDA approval June 26 ("The Tan Sheet" June 30, p. 2)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel